Biochemical, mechanical, and morphological properties of a completely autologous platelet-rich wound sealant

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 4, 2012, Pages 290-295

  Wu, Xiuwen ^a   Ren, Jianan ^a   Luan, Jianfeng ^b   Yao, Gengong ^b   Li, Jieshou ^a  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

fibrin glue; fibronectin; platelets; scanning electron microscope; thromboelastography

Indexed keywords

ADHESIVE AGENT; BIOSEAL; COLLAGEN; FIBRIN GLUE; FIBRINOGEN; FIBRONECTIN; GLOBULIN; GLUE; SEALANT; THROMBIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOCHEMISTRY; BIOMECHANICS; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRYOPRECIPITATE; ELASTICITY; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; KINETICS; MALE; PRIORITY JOURNAL; PRODUCTIVITY; TENSILE STRENGTH; THROMBOCYTE MEMBRANE; THROMBOCYTE RICH PLASMA; THROMBOELASTOGRAPHY; WOUND;

ADULT; ANIMALS; FACTOR VIII; FEMALE; FIBRIN TISSUE ADHESIVE; FIBRINOGEN; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; SWINE; TENSILE STRENGTH; THROMBELASTOGRAPHY; THROMBIN; TISSUE ADHESIVES;

EID: 84862812259     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328351ad12     Document Type: Article

References (25)

1. Bergel S. On the functions of fibrins. Dtsch Med Wochenschr 1909;35:633-665.
2. Carless PA, Anthony DM, Henry DA. Systematic review of the use of brin sealant to minimize perioperative allogeneic blood transfusion. Br J Surg 2002;89:695-703.
3. Currie LJ, Sharpe JR, Martin R. The use of brin glue in skin grafts and tissueengineered skin replacements: a review. Plast Reconstr Surg 2001;108:1713-1726.
4. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001;182(2 Suppl):1S-7S.
5. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55:1294-1299.
6. Davis BR, Sandor GK. Use of fibrin glue in maxillofacial surgery. J Otolaryngol 1998;27:107-112.
7. Mosesson MW. Fibrinogen and fibrin polymerization and functions. Blood Coagul Fibrinolysis 1999;10(1 Suppl):S45-S58.
8. Horowitz B, Busch M. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin. Transfusion 2008;48:1739-1753.
9. Chouhan VD, De La Cadena RA, Nagaswami C, Weisel JW, Kajani M, Rao AK. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin. Effect on blood coagulation, protein C activation and platelet function. Thromb Haemost 1997;77:343-349.
10. Thorn JJ, Sorensen H, Weis-Fogh U, Andersen M. Autologous brin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg 2004;33:95-100.
11. Siedentrop KH, Harris DM, Ham K, Sanchez B. Extended experimental and preliminary surgical findings with autologous fibrin tissue adhesive made from patient's own blood. Laryngoscope 1986;69:1062-1064.
12. Silberstein LE, Williams LJ, Hughlett DA, Magee DA, Weisman RA. An autologous fibrinogen-based adhesive for use in otologic surgery. Transfusion 1988;28:319-321.
13. Kjaergard HK, Weis-Fogh US, Sørensen H, Thiis J, Rygg I. Autologons fibrin glue-preparation and clinical use in thoracic surgery. Eur J Cardiothorac Surg 1992;6:52-54.
14. Corbett SA, Lee L, Wilson CL, Schwarzbauer JE. Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectinfibrin matrix. J Biol Chem 1997;272:24999-25005.
15. de Obarrio JJ, Araúz-Dutari JI, Chamberlain TM, Croston A. The use of autologous growth factors in periodontal surgical therapy: platelet gel biotechnology-case reports. Int J Periodont Restorative Dent 2000;20:486-497.
16. Carter CA, Jolly DG, Worden CE, Hendren DG, Kane CJ. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003;74:244-255.
17. Ren JA, Wu XW, Hong ZW, Li JS. Management of a patient with colocutaneous fistula by autologous platelet-rich fibrin glue. Am Surg 2012;78:e86-e87.
18. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e56-e60.
19. Glidden PF, Malaska C, Herring SW. Thromboelastograph assay for measuring the mechanical strength of fibrin sealant clots. Clin Appl Thromb Hemost 2000;6:226-233.
20. Hickerson WL, Nur I, Meidler R. A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants. Blood Coagul Fibrinolysis 2011;22:19-23.
21. Kjaergard HK, Weis-Fogh US. Important factors influencing the strength of autologous fibrin glue; the fibrin concentration and reaction timecomparison of strength with commercial fibrin glue. Eur Surg Res 1994;26:273-276.
22. Albala DM. Fibrin sealants in clinical practice. Cardiovasc Surg 2003;11(1 Suppl):5-11.
23. Altmeppen J, Hansen E, Bonnländer GL, Horch RE, Jeschke MG. Composition and characteristics of an autologous thrombocyte gel. J Surg Res 2004;117:202-207.
24. Buchta C, Dettke M, Funovics PT, Höcker P, Knöbl P, Macher M, et al. Fibrin sealant produced by the CryoSeal FS System: product chemistry, material properties and possible preparation in the autologous preoperative setting. Vox Sang 2004;86:257-262.
25. Casali B, Rodeghiero F, Tosetto A, Palmieri B, Immovilli R, Ghedini C, et al. Fibrin glue from single-donation autologous plasmapheresis. Transfusion 1992;32:641-643.